KOLINPHARMA
I prodotti Kolinpharma
Press review
From Kolinpharma world
05/12/2024
Science is the best ally of health

KOLINPHARMA®: the company founded in 2013 with headquarters in lainate (mi) is a leader in the formulation of neurological, osteo-articular and uro-gynecological nutraceutical products

When it comes to health, medicine and pharmaceuticals can count on an important ally: nutraceuticals, that is, the fertile meeting between nutrition and pharmaceuticals, which exploits the nutritional principles contained in foods that have beneficial effects on health. Even in this field, it is therefore essential to rely on expert professionals and on companies that have solid expertise and continuous training. This is the case of Kolinpharma®, a nutraceutical company in Lainate, in the Milan area, which since 2013 has combined a very high level of quality with an innovative capacity guaranteed throughout the supply chain.

The Cornerstones

"We are an innovative SME, capable of providing unique products, always patented and multi-certified", says Rita Paola Petrelli, president and founder of Kolinpharma®, a company that is now present in three large areas of medicine: neurological, osteo-articular and uro-gynecological. "Within an extremely competitive market like the one in which we operate, we have numerous distinctive characteristics: the first of all is the constant attention to research and development and preclinical studies", continues Petrelli, who also underlines the attention to the training of medical-scientific informants: "These are the elements that always determine a very open and transparent dialogue with our interlocutor, namely the medical specialist". To do this, in addition to choosing to invest in each resource within the company, Kolinpharma® creates quality products with added value, as it is always documented with objective data

The evidence of the data

It is essential to bring forward scientific evidence – explains Petrelli - Although it is not a mandatory path in the nutraceutical sector, because the legislation does not impose it, this was our choice of field: we testify with objective data what we declare about each product, its quality, goodness and usefulness», underlines the president and founder. A fundamental ally of the company, in this sense, is the almost spasmodic attention in identifying raw materials of the highest quality: «Of course they must be safe – explains Rita Paola Petrelli – Furthermore, at the base of our products there are technologically advanced substances to which the application of technologies, already known in the pharmaceutical field, allows us to overcome the limits of bioavailability and maximize the beneficial effects». These peculiarities are accompanied by the specialization of Kolinpharma's medical-scientific representatives, which invests heavily in the training of resources starting from their inclusion in the company and uses universities and centers for conducting studies, the results of which will become a tool for presenting products to doctors. This is the path that also leads to the patenting of formulas, so much so that today the company boasts 51 Italian and international patents for products formulated within the Research and Development department of Kolinpharma and marketed under the same brand.

Founder Petrelli: «What we do is always supported by evidence and specific studies»

 

The company has a department entirely dedicated to research on esg topics

A commitment for environment and society at the basis of growth

Kolinpharma®, an Italian company that has been a leading player in the nutraceutical sector for over 10 years, today has about 120 resources and operates in the medical-scientific information sector covering the entire national territory. The company is represented by a Medical Scientific Department also dedicated to Research and Development, the beating heart of Kolinpharma®.

ESG

Another important aspect is linked to ESG issues, that is, attention to social issues, the environment and governance, which has always been alongside economic-financial relations. The company is also committed to the issue of gender equality, as over half of its resources are women. But that's not all: « Sustainability is at the heart of our corporate values, which is why we have undertaken a concrete initiative to reduce our environmental impact: the planting of a thousand trees, a significant contribution to offset the carbon dioxide produced by company vehicles», explains the founder and president, Rita Paola Petrelli.

The recognition

Kolinpharma’s more than ten years of commitment and passion for nutraceuticals have earned it numerous awards: one of the most prestigious is the “100 Excellences” Award, presented last December 6th in Montecitorio. «We were the only nutraceutical company awarded – adds the president – ​​It is a clear testimony of how important it is to compete even with larger companies, proof that commitment and passion are rewarded». «On the other hand – concludes Petrelli – the end of 2023 also saw us positioned in 49th place out of 3,000 in the ranking of nutraceutical companies»

On December 6, Kolinpharma® received the prestigious “100 Excellences” Award, delivered at Montecitorio

Our Products

Among the most representative products of Kolinpharma® there is certainly KYMAX®, formulated for well-being in a specific area of ​​neurology, that is, for people who suffer from non-motor disorders typical of Parkinson's. «It was patented and entered the market in 2024 and it was an extremely challenging achievement because we address particularly sensitive and complex patients», explains the founder Rita Paola Petrelli.

In the osteoarticular field, all the products are innovative and patented, with XINEPA® which, developed for the well-being of the peripheral nervous system, has a double patent for formulation and technology in Italy, the USA and Israel. In the urogynecological field, instead, we can mention MILEDIX®, formulated for the management of typical menstrual cycle disorders: «These are problems that since adolescence are treated only with the contraceptive pill, which however is not free from side effects.

For this reason we studied a formulation that can alleviate typical states such as mood swings, irritability, tiredness, muscle tension and which therefore can compromise daily life activities»


< Back
Ultime news
Kolinpharma announces editorial collaboration with Edit Symposia
07/02/2025
Kolinpharma announces editorial collaboration with Edit Symposia
Science is the best ally of health
05/12/2024
Science is the best ally of health
“Science accuracy and listen to people”
“Science accuracy and listen to people”